Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Valens Company, formerly known as Transnational Cannabis and Valens GroWorks, is a leading cannabis-focused biotechnology and manufacturing firm specializing in high-quality extraction and product development. Based in Canada, the company operates as a premier CDMO, providing proprietary extraction services including CO2, ethanol, hydrocarbon, and solventless processes. Their business spans the production of medical-grade cannabinoid extracts, white-label manufacturing for vapes, edibles, and beverages, and the development of proprietary delivery technologies. Following a period of rapid expansion in the global cannabis market, the company was acquired by SNDL in early 2023, integrating its advanced manufacturing capabilities into one of the largest vertically integrated cannabis operations in North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Transnational Cannabis.